645 related articles for article (PubMed ID: 23332765)
1. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.
Burd CE; Sorrentino JA; Clark KS; Darr DB; Krishnamurthy J; Deal AM; Bardeesy N; Castrillon DH; Beach DH; Sharpless NE
Cell; 2013 Jan; 152(1-2):340-51. PubMed ID: 23332765
[TBL] [Abstract][Full Text] [Related]
2. The molecular balancing act of p16(INK4a) in cancer and aging.
LaPak KM; Burd CE
Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.
Liu Y; Johnson SM; Fedoriw Y; Rogers AB; Yuan H; Krishnamurthy J; Sharpless NE
Blood; 2011 Mar; 117(12):3257-67. PubMed ID: 21245485
[TBL] [Abstract][Full Text] [Related]
5. p16
Novais EJ; Diekman BO; Shapiro IM; Risbud MV
Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
[TBL] [Abstract][Full Text] [Related]
6. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin II; Leonova KI; Consiglio CR; Gollnick SO; Chernova OB; Gudkov AV
Aging (Albany NY); 2017 Aug; 9(8):1867-1884. PubMed ID: 28768895
[TBL] [Abstract][Full Text] [Related]
7. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
[TBL] [Abstract][Full Text] [Related]
8. Sustained p16
Palacio L; Krishnan V; Le NL; Sharpless NE; Beauséjour CM
Oncogene; 2017 Mar; 36(9):1309-1314. PubMed ID: 27568978
[TBL] [Abstract][Full Text] [Related]
9. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.
Romagosa C; Simonetti S; López-Vicente L; Mazo A; Lleonart ME; Castellvi J; Ramon y Cajal S
Oncogene; 2011 May; 30(18):2087-97. PubMed ID: 21297668
[TBL] [Abstract][Full Text] [Related]
10. Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.
Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin I; Leonova K; Polinsky A; Chernova OB; Gudkov AV
Aging (Albany NY); 2016 Jul; 8(7):1294-315. PubMed ID: 27391570
[TBL] [Abstract][Full Text] [Related]
11. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
12. Murine mesenchymal cells that express elevated levels of the CDK inhibitor p16(Ink4a) in vivo are not necessarily senescent.
Frescas D; Hall BM; Strom E; Virtuoso LP; Gupta M; Gleiberman AS; Rydkina E; Balan V; Vujcic S; Chernova OB; Gudkov AV
Cell Cycle; 2017 Aug; 16(16):1526-1533. PubMed ID: 28650766
[TBL] [Abstract][Full Text] [Related]
13. Cells exhibiting strong
Liu JY; Souroullas GP; Diekman BO; Krishnamurthy J; Hall BM; Sorrentino JA; Parker JS; Sessions GA; Gudkov AV; Sharpless NE
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2603-2611. PubMed ID: 30683717
[TBL] [Abstract][Full Text] [Related]
14. Radiation-Induced Senescence in p16+/LUC Mouse Lung Compared to Bone Marrow Multilineage Hematopoietic Progenitor Cells.
Epperly MW; Shields D; Fisher R; Hou W; Wang H; Hamade DF; Mukherjee A; Greenberger JS
Radiat Res; 2021 Sep; 196(3):235-249. PubMed ID: 34087939
[TBL] [Abstract][Full Text] [Related]
15. p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.
Helman A; Klochendler A; Azazmeh N; Gabai Y; Horwitz E; Anzi S; Swisa A; Condiotti R; Granit RZ; Nevo Y; Fixler Y; Shreibman D; Zamir A; Tornovsky-Babeay S; Dai C; Glaser B; Powers AC; Shapiro AM; Magnuson MA; Dor Y; Ben-Porath I
Nat Med; 2016 Apr; 22(4):412-20. PubMed ID: 26950362
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the Bmi-1/p16(Ink⁴a) pathway provokes an aging-associated decline of submandibular gland function.
Yamakoshi K; Katano S; Iida M; Kimura H; Okuma A; Ikemoto-Uezumi M; Ohtani N; Hara E; Maruyama M
Aging Cell; 2015 Aug; 14(4):616-24. PubMed ID: 25832744
[TBL] [Abstract][Full Text] [Related]
18. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
19. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.
Yousefzadeh MJ; Zhao J; Bukata C; Wade EA; McGowan SJ; Angelini LA; Bank MP; Gurkar AU; McGuckian CA; Calubag MF; Kato JI; Burd CE; Robbins PD; Niedernhofer LJ
Aging Cell; 2020 Mar; 19(3):e13094. PubMed ID: 31981461
[TBL] [Abstract][Full Text] [Related]
20. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
